Yanyan Wang

No.2, People's Street
Jinzhou, 121001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Association Between the Lymphocyte-to-High-Density Lipoprotein Cholesterol Ratio and Bone Mineral Density: A Cross-Sectional Study Based on NHANES 2011-2018.

Association Between the Lymphocyte-to-High-Density Lipoprotein Cholesterol Ratio and Bone Mineral Density: A Cross-Sectional Study Based on NHANES 2011-2018.

Journal: Journal of the American Nutrition Association
Published: November 25, 2025

Exploring Extracellular Vesicles: A Novel Approach in Nonalcoholic Fatty Liver Disease.

Exploring Extracellular Vesicles: A Novel Approach in Nonalcoholic Fatty Liver Disease.

Journal: Journal of agricultural and food chemistry
Published: January 23, 2025

Potential anticancer effects of sodium-glucose cotransporter protein 2 (SGLT2) inhibitors Canagliflozin and Dapagliflozin.

Potential anticancer effects of sodium-glucose cotransporter protein 2 (SGLT2) inhibitors Canagliflozin and Dapagliflozin.

Journal: Cancer chemotherapy and pharmacology
Published: December 14, 2024

Enhanced antireflection and absorption in thin film GaAs solar cells using dielectric composite nanostructures.

Enhanced antireflection and absorption in thin film GaAs solar cells using dielectric composite nanostructures.

Journal: Heliyon
Published: August 19, 2024

HRD1 functions as a tumor suppressor in ovarian cancer by facilitating ubiquitination-dependent SLC7A11 degradation.

HRD1 functions as a tumor suppressor in ovarian cancer by facilitating ubiquitination-dependent SLC7A11 degradation.

Journal: Cell cycle (Georgetown, Tex.)
Published: February 22, 2023

BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation.

BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation.

Journal: Frontiers in oncology
Published: May 25, 2022

Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-κB pathway.

Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-κB pathway.

Journal: Histochemistry and cell biology
Published: November 10, 2021

High expression of LASS2 is associated with unfavorable prognosis in patients with ovarian cancer.

High expression of LASS2 is associated with unfavorable prognosis in patients with ovarian cancer.

Journal: Journal of cellular physiology
Published: October 18, 2018

Low expression of CRISP3 predicts a favorable prognosis in patients with mammary carcinoma.

Low expression of CRISP3 predicts a favorable prognosis in patients with mammary carcinoma.

Journal: Journal of cellular physiology
Published: October 15, 2018

Co‑expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis.

Co‑expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis.

Journal: International journal of molecular medicine
Published: July 12, 2018

High expression of glutamate-ammonia ligase is associated with unfavorable prognosis in patients with ovarian cancer.

High expression of glutamate-ammonia ligase is associated with unfavorable prognosis in patients with ovarian cancer.

Journal: Journal of cellular biochemistry
Published: December 04, 2017

Adipokine RBP4 drives ovarian cancer cell migration.

Adipokine RBP4 drives ovarian cancer cell migration.

Journal: Journal of ovarian research
Published: November 30, 2017
Showing 1-12 of 19

Last Updated: 09/26/2026